Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
LEVEL 1 STARTER
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Glaxosmithkline | GSK | NYSE | Ordinary Share |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.195 | -0.49% | 39.93 | 40.02 | 39.84 | 39.85 | 40.12 | 13:53:16 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,728 | 886,467 | $ 39.95 | $ 35,412,911 | 2,366,957 | 35.90 - 42.37 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:53:51 | 3 | $ 39.93 | USD |
Glaxosmithkline Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 99.54B | 2.49B | $ 4.83B | 1.47 | 27.10 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.98 | 4.96% | 05/16/2019 | - | 12.60% |
Glaxosmithkline News
PROMOTEDThis Cannabis Company Increased Revenue by 1000% IHNW • Mon Jun 17, 2019 7:02 AM (7 hours ago)
Morphic Holding Sets IPO at 5 Million Shares; Sees Pricing at $14-$16 Apiece Dow Jones News • Fri Jun 14, 2019 8:04 AM (3 days ago)
Report of Foreign Issuer (6-k) Edgar (US Regulatory) • Wed Jun 12, 2019 1:32 PM (5 days ago)
Report of Foreign Issuer (6-k) Edgar (US Regulatory) • Fri Jun 07, 2019 6:38 AM (1 week ago)
Nucala (mepolizumab) Gains FDA Approval for Two New Self-Administration Options Business Wire • Thu Jun 06, 2019 5:15 PM (2 weeks ago)
Report of Foreign Issuer (6-k) Edgar (US Regulatory) • Tue Jun 04, 2019 6:22 AM (2 weeks ago)
Report of Foreign Issuer (6-k) Edgar (US Regulatory) • Mon Jun 03, 2019 11:12 AM (2 weeks ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GSK Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 40.07 | 40.44 | 39.84 | 40.2100 | 2M | 3M | 2M | -0.145 | -0.36% |
| 1 Month | 39.28 | 40.44 | 38.35 | 39.5198 | 2M | 3M | 2M | 0.645 | 1.64% |
| 3 Months | 41.26 | 42.37 | 38.35 | 40.3487 | 2M | 7M | 3M | -1.335 | -3.24% |
| 6 Months | 37.45 | 42.37 | 35.9 | 39.6917 | 1M | 15M | 3M | 2.475 | 6.61% |
| 1 Year | 41.04 | 42.37 | 35.9 | 39.8633 | 809k | 15M | 3M | -1.115 | -2.72% |
| 3 Years | 40.58 | 45.58 | 34.52 | 39.7738 | 809k | 21M | 3M | -0.655 | -1.61% |
| 5 Years | 53.87 | 54.8 | 34.52 | 41.5234 | 31k | 21M | 3M | -13.945 | -25.89% |
Glaxosmithkline Description
| GlaxoSmithKline PLC incorporated in United Kingdom. The Company creates, discoveres, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products. |
